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Introduction: The technique of selective embolization has been applied for years in the treatment of vascular
anomalies, severe hemorrhage, and for benign and malignant tumors. Some hypervascular skeletal metastases are
prone to massive hemorrhage.
Case presentation: We describe the cases of two patients with thyroid carcinoma presenting with neuromuscular
symptoms due to large skeletal metastases in the shoulder and sternum respectively. Pre-operative percutaneous
selective catheterizations of the arteries feeding the metastatic tumors were performed, followed by infusion of
gelfoam. The procedures were technically successful in both patients without adverse effects or bleeding. Complete
resections of the skeletal metastases were then performed without substantial bleeding.
Conclusion: Selective embolization is an effective treatment for bony metastases from thyroid cancer.
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Well-differentiated thyroid carcinoma with bony metasta-
ses to the sternum or clavicle is uncommon. Patients with
metastatic disease from thyroid carcinoma have a poor
prognosis in general. However, adjuvant therapy may
reduce the tumor burden in some patients, offering a
survival or palliative benefit. Treatment modalities for
patients with metastatic thyroid cancer include surgical
excision, radioactive iodine (RAI) therapy with I-131,
external beam radiotherapy, or novel therapies through
recruitment into clinical trials. Large primary tumors and
bony metastases are predictive of a poor response to RAI
therapy. Complete surgical resection of isolated symp-
tomatic metastases has been associated with improved
survival and should be considered. For skeletal metasta-
ses in particular, surgery is recommended for symptom-
atic as well as asymptomatic lesions in weight-bearing
extremities [1,2].
Numerous studies have indicated that a large proportion
of skeletal metastases from thyroid carcinoma are hyper-
vascular, with bleeding consequently the most common* Correspondence: hyson79@gmail.com
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A few studies recommend embolization before resection
of these bony metastases [2-4].
Bone metastases from thyroid carcinoma to the sternum
and clavicle are uncommon and have been reported only
rarely. We present two cases of thyroid cancer with bony
metastases to the sternum and clavicle, and describe




A 71-year-old man presented to our center with a three-
year history of a painful, progressively enlarging mass
over his left clavicle and shoulder (Figure 1A). Physical
examination revealed a 10×10cm mass of his left clavicle
extending to involve his left shoulder. A positron emission
tomography-computed tomography showed a right thy-
roid tumor with bone metastases to his left clavicle and
shoulder (Figure 1B). There were also multiple indeter-
minate nodules in the isthmus and left lobe of his thyroid
gland on sonography (Figure 1C). A diagnosis of metastatic
thyroid carcinoma was made after an incisional biopsy
of the left clavicular mass (Figure 1D). There was heavy
bleeding during the biopsy, with a large amount of post-
procedural hemorrhagic drainage.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A 71-year-old man presented with a painful enlarging
mass over the left clavicle. (A) Physical examination. (B) Positron
emission tomography reveals a right thyroid tumor with a left
clavicular metastasis. (C) Angiographic image from selective
catheterization of the left subclavian artery. (D) Follow-up
angiography after embolization shows no residual tumoral blush.
Figure 2 A 64-year-old woman presented with an enlarging
mass of the upper sternum. (A) Physical examination. (B) Positron
emission tomography showed a right thyroid tumor with a sternal
metastatic lesion. (C) Angiographic image from selective catheterization
of the left internal mammary artery. (D) Follow-up angiography after
embolization reveals no residual tumoral blush.
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catheterization of the arteries feeding the metastatic le-
sion was performed, followed by infusion of absorbable
gelatin sponge particles (Cutanplast®; Mascia Brunelli
Spa, Milano, Italy). The clavicular mass was fed by
branches of the left subclavian artery. Additional
selective micro-catheterization and embolization were
performed on four feeding arteries (likely arising from
the transverse cervical, suprascapular, clavicular and
acromial branches of the thoracoacromial arteries) with
gelfoam. There was no acute complication encountered
during or following embolization.
A total thyroidectomy with wide composite resection of
the large clavicular mass was performed the following day.
The metastatic lesion was easily separated from his left
clavicle following complete tumor devascularization and
necrosis by the pre-operative embolization. The estimated
blood loss was low. Our patient received post-operative
RAI (I-131) therapy. His post-operative recovery was un-
eventful, and he has been well and pain-free since surgery.
Case 2
A 64-year-old woman presented to our center with a pain-
ful hard mass over the upper part of her sternum. She had
a history of a thyroid tumor 30 years ago but did not
undergo surgery. The sternal mass was progressively
enlarging and had been present for a month. On physical
examination, a 4.0×3.7cm mass was found in her upper
sternum extending to the region of the clavicular heads.Positron emission tomography-computed tomography
revealed a 3.3cm tumor in her right thyroid gland and
another 4.0cm upper sternal osteolytic mass (Figure 2B).
A diagnosis of metastatic follicular carcinoma was made
via fine-needle aspiration cytology of the sternal mass.
Catheter angiography was performed prior to embolization
to identify the feeding vessels supplying the metastatic
lesion and to determine the feasibility and safety of
embolization. These arteries were then catheterized, the
choice of catheter depended upon the size of the feeding
vessels. Infusion of absorbable gelatin sponge particles
(Cutanplast®; Mascia Brunelli Spa) was performed following
selective catheterization of the feeding vessels. The sternal
metastatic mass was fed by branches of the internal mam-
mary arteries bilaterally. There was no immediate compli-
cation encountered during or after embolization.
Our patient subsequently underwent a total thyroidec-
tomy, with partial sternectomy for the metastatic lesion
using a sternal saw. Sternal reconstruction was performed
with bone cement and Malex mesh. The procedure was
technically straightforward after the complete devasculari-
zation and necrosis of the sternal metastasis, which re-
sulted in tumor ischemia and hypovascularity.
Our patient received post-operative RAI (I-131) therapy.
No evidence of cancer recurrence or distant metastasis
was detected during subsequent follow-up visits.
Discussion
Distant metastasis occurs in 10% to 20% of well-
differentiated thyroid carcinoma, most frequently to
the lung and bone. RAI therapy is the gold-standard
for treatment and remains a primary treatment
Son et al. Journal of Medical Case Reports 2014, 8:405 Page 3 of 4
http://www.jmedicalcasereports.com/content/8/1/405modality for metastatic thyroid carcinoma, but poor
tumor uptake of the agent can limit its usefulness. Re-
sults of ablation therapy are good with lung metasta-
ses, but bone metastases are not cured with ablation
therapy alone. As such, osseous metastasis in differen-
tiated thyroid carcinoma confers a significantly worse
prognosis. Treatment options in patients with bone me-
tastases from differentiated thyroid carcinoma are limited
and mostly palliative. Other treatment modalities include
surgery or external irradiation. Our report describes two
cases of differentiated thyroid carcinoma with clavicular
and sternal metastases that were managed successfully by
surgery with pre-operative embolization. This demon-
strated the effectiveness of embolization in the manage-
ment of isolated skeletal metastasis from differentiated
thyroid carcinoma [3,5,6].
Surgery is indicated as first-line therapy in individual
patients and should be advocated in cases of solitary
bone metastasis. This therapeutic approach occasionally
remains the only chance of offering a long-term cure
with an improved quality of life and prolonged survival
in cases where isolated metastases are amenable to re-
section. Furthermore, with multiple metastases or local
recurrent disease, resection of skeletal metastases can
allow for more efficient radio-iodine treatment, mak-
ing surgical removal of resectable skeletal metastases a
valuable complement to RAI therapy. Zettinig et al.
identified surgical extirpation of bone metastases as a
significant prognostic factor associated with improved
survival in patients with distant metastases limited to
the bones. This study concluded that in patients without
additional extraskeletal distant metastases, radical surgical
extirpation of bone metastases may be associated with
improved survival [1-3,6,7].
Bleeding is the most common complication encoun-
tered at operation for these skeletal metastases. More
than 60% of skeletal metastases, including those to the
spine, demonstrate hypervascularity and neovascularity.
Efforts have been made to decrease the incidence of
intra-operative hemorrhage [8,9].
Embolization was first reported by Dr Frieda Feldman
in 1975 as a useful adjunct in the management of selective
bone tumors. Many studies have since reported on select-
ive and super-selective intra-arterial embolization as an
effective treatment with a rapid reduction in pain and
tumor volume of primary bone and soft tissue tumors,
including bony metastases from various primary malignan-
cies. Embolization provides for devascularization, size
reduction, calcification of margins, and pain relief; it can be
palliative or adjunctive, as well as primary or serial [2,6-9].
The main purpose of embolization is to occlude as
much of the tumor vascular supply as possible, yet avoid-
ing damage to adjacent normal tissue. The outcomes
range from complete tumor devascularization andnecrosis to various degrees of ischemia and hypovascular-
ity. This would ideally lead to tumor shrinkage, reduced
intra-operative bleeding, and clearer delineation of mar-
gins between the tumor and surrounding tissues, thus
allowing for easier resection. Decreased intra-operative
bleeding is particularly important in patients with rare
blood groups or in those prone to transfusion reactions.
This is crucial considering that high transfusion require-
ments in tumor surgery are frequently complicated by de-
pletion of clotting factors and coagulopathy that may
further exacerbate intra-operative bleeding, while blood
salvage techniques are contraindicated because of the risk
of dissemination of tumor cells. In addition, in large and
unresectable tumors, decreasing the volume of viable
tumour tissue, destroying the tumor tissue, or at least
inhibiting tumor growth will decrease the required doses
of radiotherapy and chemotherapy [2,6,9].
Therapeutic embolization of osseous metastases has
been previously reported in a small number of patients
with a variety of tumors. This procedure has also been
shown to result in a rapid resolution of associated
neurological symptoms. In our patients, it was believed
that selective arterial embolization might be inadequate
in controlling intra-operative bleeding, not only due to
the size of the metastases but also because of resistance
to pharmaceutical antiangiogenic manipulations. Thus,
the treatment plan of these patients included surgery
closely following embolization [2,6,9,10].
Gelfoam or gelatin sponge is a dissolvable sponge-like
material that has been used for many years in surgery. It
comes in small, flat, rectangular blocks that can be either
cut with scissors into elongated rectangles or rolled into
pledgets and injected via diagnostic catheters or micro-
catheters. Alternatively, the material can be cut into small
cubes and mixed vigorously in a syringe to form a slurry
(two syringes connected via a stopcock works well). Gel-
foam is considered a temporary occluding agent, with the
occluded vessel re-canalizing in two to four weeks,
although the evidence for the exact timeframe is limited
[7,9,11].
Conclusion
In view of the insensitivity of bone metastasis to RAI ther-
apy, the authors believe that pre-operative embolization
followed by definitive surgery of solitary osseous metasta-
sis from thyroid carcinoma is a safe and effective treat-
ment option, even in technically demanding anatomical
locations.
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